IRIS UniCatt

Citterio, Franco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 16.176
NA - Nord America 7.033
AS - Asia 4.618
SA - Sud America 931
Continente sconosciuto - Info sul continente non disponibili 205
AF - Africa 193
OC - Oceania 15
Totale 29.171
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 11.277
US - Stati Uniti d'America 6.848
SG - Singapore 2.285
DE - Germania 1.129
CN - Cina 969
NL - Olanda 758
BR - Brasile 757
SE - Svezia 652
UA - Ucraina 533
FR - Francia 490
VN - Vietnam 380
IE - Irlanda 270
GB - Regno Unito 233
IN - India 182
PL - Polonia 180
FI - Finlandia 167
ID - Indonesia 166
JP - Giappone 126
RU - Federazione Russa 122
CA - Canada 92
BD - Bangladesh 86
ES - Italia 78
TR - Turchia 77
CH - Svizzera 73
HK - Hong Kong 67
IQ - Iraq 63
AR - Argentina 57
CI - Costa d'Avorio 52
BE - Belgio 50
MX - Messico 49
ZA - Sudafrica 39
IR - Iran 28
MA - Marocco 26
SA - Arabia Saudita 23
VE - Venezuela 23
PK - Pakistan 22
AT - Austria 21
CO - Colombia 21
EC - Ecuador 20
CL - Cile 19
KE - Kenya 18
AL - Albania 15
CZ - Repubblica Ceca 15
EG - Egitto 15
PH - Filippine 14
RO - Romania 13
UZ - Uzbekistan 13
AU - Australia 12
BG - Bulgaria 12
JM - Giamaica 12
AE - Emirati Arabi Uniti 11
GR - Grecia 11
KR - Corea 11
TN - Tunisia 11
LT - Lituania 10
IL - Israele 9
MY - Malesia 9
NP - Nepal 9
PE - Perù 9
PT - Portogallo 9
DZ - Algeria 8
PY - Paraguay 8
TH - Thailandia 8
TW - Taiwan 8
UY - Uruguay 8
AZ - Azerbaigian 7
HU - Ungheria 7
JO - Giordania 7
ET - Etiopia 6
HN - Honduras 6
KZ - Kazakistan 6
SI - Slovenia 6
SK - Slovacchia (Repubblica Slovacca) 6
BH - Bahrain 5
DK - Danimarca 5
KG - Kirghizistan 5
NO - Norvegia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
GE - Georgia 4
MD - Moldavia 4
NG - Nigeria 4
NI - Nicaragua 4
OM - Oman 4
PA - Panama 4
RS - Serbia 4
SM - San Marino 4
BA - Bosnia-Erzegovina 3
BB - Barbados 3
BY - Bielorussia 3
CV - Capo Verde 3
GT - Guatemala 3
GY - Guiana 3
IS - Islanda 3
NZ - Nuova Zelanda 3
PR - Porto Rico 3
QA - Qatar 3
A1 - Anonimo 2
AM - Armenia 2
CR - Costa Rica 2
Totale 28.935
Salva come PNG Salva come JPEG
Città #
Singapore 1.106
Milan 1.088
Chandler 1.028
Rome 783
Ashburn 704
San Jose 577
Naples 354
Dublin 254
Jacksonville 251
San Mateo 246
New York 244
Beijing 238
Turin 207
Florence 178
Wilmington 164
Jakarta 153
Bologna 152
Palermo 142
Lauterbourg 133
Ho Chi Minh City 129
Nanjing 129
Ann Arbor 127
Los Angeles 127
Boston 126
Hanoi 116
Bari 113
Fairfield 111
Catania 105
Tokyo 101
Genoa 98
Warsaw 98
Lawrence 94
Cattolica 93
Dearborn 79
Verona 77
Dallas 73
Houston 71
Redwood City 67
Moscow 66
Chicago 65
Buffalo 64
Frankfurt am Main 63
Brescia 59
Hong Kong 59
The Dalles 58
São Paulo 56
Seattle 55
Princeton 54
Abidjan 52
Kraków 50
Nürnberg 49
Santa Clara 49
Woodbridge 48
Padova 45
Hefei 44
Munich 44
Orem 43
Parma 41
Reggio Emilia 41
Helsinki 40
Venice 40
Cagliari 39
Guangzhou 39
Nanchang 39
Bergamo 38
Brussels 38
Taranto 37
Pescara 36
Rio de Janeiro 36
Redmond 35
Mountain View 34
Perugia 34
Messina 33
Madrid 32
San Francisco 32
Boardman 31
Brooklyn 30
London 30
Hangzhou 29
Lancaster 29
Toronto 29
Livorno 28
Paris 28
Shenyang 28
Norwalk 27
University Park 27
Izmir 26
Lucca 26
Amsterdam 25
Augusta 25
Hebei 25
Salerno 25
Marseille 23
Modena 23
Monza 23
Rimini 23
Belo Horizonte 22
Bremen 22
Atlanta 21
Changsha 21
Totale 12.269
Salva come PNG Salva come JPEG
Nome #
Le disfunzioni sessuali maschili in pazienti con insufficienza renale cronica end stage ed in pazienti sottoposti a trapianto renale 12.221
Process control: simply a matter of efficiency or of survival and costs? A single-centre quality improvement project in living donor renal transplant 205
Accidental transplantation of a kidney with stones: case report 200
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: results from a preliminary cross-sectional study 193
Increased cancer risk in patients undergoing dialysis: A population-based cohort study in North-Eastern Italy 193
N-Acetylcysteine and High-Dose Atorvastatin Reduce Oxidative Stress in an Ischemia-Reperfusion Model in the Rat Kidney 189
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors. 188
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 182
Contrast-enhanced Voiding US for Grading of Reflux in Adult Patients Prior to Antireflux Ureteral Implantation1 178
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results 174
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 174
LAPDOCTOR: TELL ME HOW DIFFICULT WILL BE MY DONOR 173
HIGH-DOSE ATORVASTATIN REDUCE OXIDATIVE STRESS OF ISCHEMIA/REPERFUSION INJURY AFTER ISOGENEIC KIDNEY TRANSPLANTATION IN RATS 172
Effects of Switching from Twice-Daily to Once-Daily Tacrolimus Formulation on Quality of Life, Anxiety, and Transplant Benefit Perception after Kidney Transplantation 169
Expanding the Living Donor Pool "Second Act": Laparoscopic Donor Nephrectomy and ABO-Incompatible Kidney Transplantation Improve Donor Recruitment 167
Early Appearance of De Novo Anti-HLA Antibodies Following Renal Transplantation: Preliminary Results of a Prospective Multicenter Study. 163
Belatacept utilization recommendations: an expert position 161
Significant improvement in patient survival after renal transplantation in the last decade. 155
Living Kidney Donation in a Type 1 Dent's Disease Patient from His Mother 154
Once Daily Everolimus Is Safe and Effective in De Novo Renal Transplant Recipients: Six-Month Results of a Pilot Study. 150
COMBINATION OF EXTENDED-RELEASE TACROLIMUS PLUS EVEROLIMUS ONCE-DAILY IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS: ER-TAC VERSUS LCPT 150
USE OF A SINGLE DOSE OF BASILIXIMAB AFTER MAJOR SURGICAL PROCEDURES IN KIDNEY TRANSPLANT RECIPIENTS 148
RENAL FUNCTION IN PATIENTS TREATED WITH BELATACEPT-OR CYCLOSPORINE-BASED REGIMENS AT YEAR 3 IN THE BENEFIT AND BENEFIT-EXT STUDIES 147
Late Calcineurin Inhibitors Introduction after Induction with Basiliximab and Thymoglobulin Is Safe and Effective in Old for Old Renal Transplantation: 1-Year Results of a Prospective Clinical Study. 147
CHYLOUS ASCITES AFTER LAPAROSCOPIC LIVING DONOR NEPHRECTOMY. CASE REPORT AND REVIEW OF THE LITERATURE 147
Preoperative Psychological Factors Predicting Graft Rejection in Patients Undergoing Kidney Transplant: A Pilot Study 146
Attachment style predict compliance, quality of life and renal function in adult patients after kidney transplant: preliminary results. 144
Complete clinical remission of psoriasis 6 months after renal transplantation 141
Metabolic Syndrome and Cardiovascular Disease in Kidney Transplantation 140
INCIDENCE AND RISK FACTORS FOR DE-NOVO CANCERS IN ITALIAN KIDNEY TRANSPLANT (KT) RECIPIENTS 140
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 139
Interventional radiological treatment of renal transplant complications: a pictorial review 139
Do patients who participate in a clinic experimental protocol have the same probability of success from that who were not selected or refused to participate? Outcome surveillance, safety, and bioethical considerations in kidney transplant clinical research 138
AN EASY ALGORITHM TO OPTIMIZE THE EXPOSURE TO TACROLIMUS AND EVEROLIMUS, WHEN USED IN COMBINATION 138
The reduction of left ventricular hypertrophy after renal transplantation is not influenced by the immunosuppressive regimen. 135
Perioperative-, recipient-, and donor-related factors affecting delayed graft function in kidney transplantation 135
Extended-Release Tacrolimus Plus Everolimus or Micophenolate Mofetil in Deceased Donor Kidney Transplant Recipients: 6-Month Results of a Prospective Randomized Clinical Trial 133
TO TRANSPLANT OR NOT TO TRANSPLANT: A KIDNEY WITH A GIANT CYST. CASE REPORT AND REVIEW OF THE LITERATURE 133
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 132
Emotional self-efficacy and alexithymia may affect compliance, renal function and quality of life in kidney transplant recipients: Results from a preliminary cross-sectional study 131
Behavioural and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 131
Tacrolimus plus mycophenolate mofetil vs. cyclosporine plus everolimus in deceased donor kidney transplant recipients: three-yr results of a single-center prospective clinical trial. 130
Summary of the International Conference on Onco-Nephrology: an emerging field in medicine 130
How Challenging Will Be My Living Donor? CT Scan and Clinical Evaluation Can Predict Technical Difficulty of Laparoscopic Donor Nephrectomy 130
Determinants of hemodynamic compensation during veno-venous bypass in liver transplantation 129
Increase in N-acetyl-beta-glucosaminidase excretion as a marker of kidney damage in cyclosporine-treated renal allografts 129
Living kidney donation from people at risk of nephrolithiasis, with a focus on the genetic forms 129
Combination of Extended-Release Tacrolimus Plus Everolimus Once Daily in Dc Novo Kidney Transplant Recipients: ER-Tac vs LCPT 129
PRELIMINARY RESULTS FROM A PROSPECTIVE MULTICENTER STUDY REVEAL THE EARLY APPEARANCE OF DE NOVO ANTI-HLA ANTIBODIES FOLLOWING RENAL TRANSPLANTATION 126
Wound Healing Complications and the Use of Mammalian Target of Rapamycin Inhibitors in Kidney Transplantation: A Critical Review of the Literature 126
Conversion from Prograf to Advagraf in stable kidney transplant recipients: better renal function after 3-year follow-up 126
Posttransplant encapsulating peritoneal sclerosis, long-term success with everolimus and low-dose CNI: a case report 126
Behavioral and demographic factors associated with occurrence of non-melanoma skin cancer in organ transplant recipients 125
ONE-SHOT VERSUS MULTIDOSE PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS AFTER KIDNEY TRANSPLANTATION: A RANDOMIZED, CONTROLLED, CLINICAL TRIAL 123
Andamento temporale di alcune proteine della fase acuta dopo trapianto di rene 121
Interventional Radiological Treatment of Renal Transplant Complications: A Pictorial Review 120
Increased incidence of cutaneous melanoma in organ transplant recipients based on a single-centre longitudinal study in Rome, Italy. 119
Evaluation of Everolimus Activity against Mycobacterium tuberculosis Using In Vitro Models of Infection 118
Inferior Long-Term Outcomes for Kidney Transplant Recipients With an Immunologically Mediated Primary Renal Disease 118
Coenzyme Q. alpha tocopherol graft uptake and lipid peroxidation in human liver transplantation: evidence of energy metabolism protection in University of Wisconsin (UW) solution-preserved livers 116
Bullous pemphigoid in a transplant recipient: is this a sign of allograft rejection? 116
Anonymity and live-donor transplantation: an ELPAT view 116
[Nitrogen loss after kidney transplantation: effects of immunosuppressive therapy] 116
Belatacept utilization recommendations: an expert position 115
COVID-19 and kidney transplantation: an Italian Survey and Consensus 115
Nonadherence to immunosuppressive therapy in kidney transplant recipients: can technology help? 114
Emotional management and quality of life in mother living versus multi-organ donor renal transplant recipients 113
"Why can't I give you my organs after my heart has stopped beating?" An overview of the main clinical, organisational, ethical and legal issues concerning organ donation after circulatory death in Italy 113
Thymoglobulin and Basiliximab vs Basiliximab as Induction Therapy in Deceased Donor Kidney Transplantation: 1-Year Results of a Prospective Clinical Trial 112
Immunosuppression with Belatacept-Based, Corticosteroid-Avoiding Regimens in De Novo Kidney Transplant Recipients 111
Global Kidney Exchange: opportunity or exploitation? An ELPAT/ESOT appraisal 111
Pharmacokinetics for once- versus twice-daily tacrolimus formulations in de novo kidney transplantation: a randomized, open-label trial 110
Evolution of causes of mortality in renal transplantation in the last 10 years 110
The Relevance of Directive 2010/53/EU for Living Organ Donation Practice: An ELPAT View 110
Enzyme-Linked Immunospot Assay as a Complementary Method to Assess and Monitor Cytomegalovirus Infection in Kidney Transplant Recipients on Pre-emptive Antiviral Therapy: A Single-Center Experience 110
Radiofrequency thermal ablation of renal graft neoplasms: A literature review 110
Once-a-Day Administration of Everolimus Is Safe in De Novo Renal Transplant Recipients: 1-Year Results of a Pilot Study 109
De Novo Malignancies after Organ Transplantation: Focus on Viral Infections 109
Spontaneous renal allograft rupture complicated by urinary leakage: case report and review of the literature 108
Isoprinosine effects on postoperative immunodepression 106
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 106
Once-a-day administration of everolimus is safe in de novo renal transplant recipients: 1-year results of a pilot study 106
Human humoral immune reactions against pig antigens: a method to clear preexisting preformed natural antibodies 105
Prediction, prevention, and management of delayed graft function: where are we now? 105
Expanding the living donor pool, "Ist Act": analysis of the causes of exclusion of potential kidney donors 105
Safety of Everolimus With Reduced Calcineurin Inhibitor Exposure in De Novo Kidney Transplants: An Analysis From the Randomized TRANSFORM Study 105
Dealing With Public Solicitation of Organs From Living Donors-An ELPAT View 104
Two-year outcomes in de novo renal transplant recipients receiving everolimus-facilitated calcineurin inhibitor reduction regimen from the TRANSFORM study 103
Everolimus and Minimization of Cyclosporine in Renal Transplantation: 24-Month Follow-Up of the EVEREST Study 101
Preoperative psychological factors predicting graft rejection in patients undergoing kidney transplant: a pilot study 101
Dealing With Public Solicitation of Organs From Living Donors--An ELPAT View 101
Belatacept utilization recommendations: an expert position 100
Everolimus with Reduced Calcineurin Inhibitor Exposure in Renal Transplantation 100
Effects of switching from twice-daily to once-daily tacrolimus formulation on quality of life, anxiety, and transplant benefit perception after kidney transplantation 99
Risk of de novo cancers after transplantation: results from a cohort of 7217 kidney transplant recipients, Italy 1997-2009 97
Cyclosporine levels together with metabolites are more effective than cyclosporine parent compound levels alone in predicting hepatic toxicity after liver transplantation 97
Raising awareness of unspecified living kidney donation: An ELPAT 97
Surgical Antibiotic Prophylaxis After Renal Transplantation: Time to Reconsider. 96
One-shot versus multidose perioperative antibiotic prophylaxis after kidney transplantation: a randomized, controlled clinical trial 96
Outcome of liver transplatation after acute rejection and sepsis 95
Totale 25.118
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.217
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.217
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.252 0 125 27 52 46 55 37 227 49 98 267 269
2022/20233.797 332 348 192 452 177 432 152 343 495 203 385 286
2023/20244.961 284 576 300 374 340 488 402 417 349 444 487 500
2024/20257.190 492 664 689 565 691 508 517 589 823 439 662 551
2025/20267.436 1.199 335 492 641 1.191 398 1.189 477 520 529 232 233
2026/2027475 415 60 0 0 0 0 0 0 0 0 0 0
Totale 29.171